<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2393-6797</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Medicina Interna ]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Urug. Med. Int.]]></abbrev-journal-title>
<issn>2393-6797</issn>
<publisher>
<publisher-name><![CDATA[Sociedad de Medicina Interna del Uruguay]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2393-67972019000300026</article-id>
<article-id pub-id-type="doi">10.26445/04.03.3</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Fibroscan como diagnóstico de hipertensión portal en pacientes cirróticos]]></article-title>
<article-title xml:lang="en"><![CDATA[Fibroscan as a diagnosis of portal hypertension in cirrhotic patients]]></article-title>
<article-title xml:lang="pt"><![CDATA[Fibroscan como diagnóstico de hipertensão portal em pacientes cirróticos]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Perez]]></surname>
<given-names><![CDATA[Laura]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pincelli]]></surname>
<given-names><![CDATA[Valentina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pittamiglio]]></surname>
<given-names><![CDATA[Lorena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez Pezzino]]></surname>
<given-names><![CDATA[Mateo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[Damián]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Saralegui]]></surname>
<given-names><![CDATA[Micaela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nieto]]></surname>
<given-names><![CDATA[Gastón]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Perendones]]></surname>
<given-names><![CDATA[Mercedes]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Chiarella]]></surname>
<given-names><![CDATA[Marcelo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de la República Facultad de Medicina Clínica Médica &#8220;2&#8221;]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>01</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>01</day>
<month>12</month>
<year>2019</year>
</pub-date>
<volume>4</volume>
<numero>3</numero>
<fpage>26</fpage>
<lpage>34</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S2393-67972019000300026&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S2393-67972019000300026&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S2393-67972019000300026&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  La hipertensión portal es un síndrome frecuente en las hepatopatías crónicas. Entre sus etiologías destaca la cirrosis hepática, responsable en la gran mayoría de los casos. Desde la incorporación de la Elastografía de Transición (Fibroscan) en Uruguay, no se han realizado estudios a nivel nacional que relacionen los resultados obtenidos mediante esta técnica con la presencia de hipertensión portal en pacientes cirróticos.  Objetivo:  Caracterizar la población cirrótica diagnosticada mediante Fibroscan, atendida en la policlínica de Hepatología del Hospital Pasteur.  Material y Métodos:  Se estudiaron los pacientes con diagnóstico de cirrosis hepática de cualquier etiología asistidos y controlados en la policlínica de Hepatología del Hospital Pasteur en el periodo de 2015 a 2018.  Resultados:  Se incluyeron 49 pacientes, de los cuales 34 presentaban hipertensión portal. Se encontró mayor prevalencia de cirrosis hepática en hombres con etiología alcohólica y por infección por virus de la hepatitis C. Se halló asociación entre valores de ET &#8805; 15 kPa y la presencia de hipertensión portal. No fue posible demostrar asociación estadísticamente significativa entre valores de ET &#8805; 15 kPa y la presencia de várices esófago gástricas y/o gastropatía por hipertensión portal.  Conclusiones:  El punto de corte utilizado en el Fibroscan es útil para diagnóstico de hipertensión portal. Es necesario continuar realizando fibrogastroscopía para el diagnóstico de la misma.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  Portal hypertension is a syndrome that is frequently present in chronic liver diseases. Within the causes that results in portal hypertension, liver cirrhosis outstands, being responsible for most cases. Since the incorporation of transient elastography (Fibroscan) in Uruguay, no research has been conducted at a national level that correlates the results obtained by Fibroscan with the presence of portal hypertension in cirrhotic patients.  Objectives:  To characterize cirrhotic population diagnosed by Fibroscan who are assisted in the Hepatology polyclinic of Hospital Pasteur.  Material and Methods:  Patients with diagnosis of liver cirrhosis of any etiology were studied, who have been assisted and monitored in the Hepatology polyclinic of Hospital Pasteur in the period 2015 - 2018.  Results:  49 patients were included, of which 34 presented elements of portal hypertension. A higher prevalence of cirrhosis was found in men with alcoholic etiology and infection with hepatitis C virus. An association was found between Fibroscan values &#8805; 15 kPa and the presence of portal hypertension. It was not possible to demonstrate a statistically significant association between Fibroscan values &#8805; 15 kPa and the presence of gastric esophageal varices and/or gastropathy due to portal hypertension.  Conclusions:  The cut-off point used in Fibroscan is useful for the diagnosis of portal hypertension. It is necessary to continue performing fibrogastroscopy for the diagnosis of portal hypertension.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo.  Introdução:  A hipertensão portal é uma síndrome comum nas doenças hepáticas crônicas. Dentre suas etiologias, destaca-se a cirrose hepática, responsável na grande maioria dos casos. Desde a incorporação da Elastografia de Transição (Fibroscan) no Uruguai, não foram realizados estudos nacionais que relacionem os resultados obtidos por essa técnica com a presença de PHT em pacientes cirróticos.  Objetivo:  Caracterizar a população cirrótica diagnosticada por Fibroscan atendida na Policlínica de Hepatologia do Hospital Pasteur.  Material e Métodos:  Foram estudados pacientes com diagnóstico de cirrose hepática de qualquer etiologia assistida e controlada na Policlínica de Hepatologia do Hospital Pasteur no período de 2015 a 2018.  Resultados: Foram incluídos no estudo 49 pacientes, dos quais 34 apresentavam elementos de hipertensão portal foi encontrada maior prevalência de cirrose hepática em homens com etiologia alcoólica e infecção pelo vírus da hepatite C. Foi encontrada associação entre valores de Fibroscan &#8805; 15 kPa e presença de hipertensão portal. Não foi possível demonstrar associação estatisticamente significante entre valores de Fibroscan &#8805; 15 kPa e presença de varizes esofágicas gástricas e / ou gastropatia por hipertensão portal.  Conclusões:  O ponto de corte utilizado no Fibroscan é útil para o diagnóstico da hipertensão portal. É necessário continuar realizando fibrogastroscopia para o diagnóstico de hipertensão portal.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Hipertensión portal]]></kwd>
<kwd lng="es"><![CDATA[elastografía de transición (Fibroscan)]]></kwd>
<kwd lng="es"><![CDATA[cirrosis hepática]]></kwd>
<kwd lng="es"><![CDATA[várices esófago-gástricas.]]></kwd>
<kwd lng="en"><![CDATA[Portal hypertension]]></kwd>
<kwd lng="en"><![CDATA[transient elastography]]></kwd>
<kwd lng="en"><![CDATA[liver cirrhosis]]></kwd>
<kwd lng="en"><![CDATA[esophageal varices.]]></kwd>
<kwd lng="pt"><![CDATA[Hipertensão portal]]></kwd>
<kwd lng="pt"><![CDATA[elastografia de transição]]></kwd>
<kwd lng="pt"><![CDATA[cirrose hepática]]></kwd>
<kwd lng="pt"><![CDATA[varizes esofágico-gástricas]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rozman Borstnar]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cardellach]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hipertensión portal y enfermedades vasculares del hígado]]></article-title>
<source><![CDATA[Farreras Rozman. Medicina interna]]></source>
<year>2016</year>
<edition>18°</edition>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pareja Q]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Restrepo G]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnostic Methods in Portal Hypertension]]></article-title>
<source><![CDATA[Rev colomb gastroenterol]]></source>
<year>2016</year>
<volume>31</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>135-45</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zeballos]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Taullard]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Semiología gastroenterológica]]></source>
<year>2003</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Oficina del Libro FEFMUR]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garcia-Tsao]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Sanyal]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Grace]]></surname>
<given-names><![CDATA[ND]]></given-names>
</name>
<name>
<surname><![CDATA[Carey]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Shuhart]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis]]></article-title>
<source><![CDATA[Vol Hepatology]]></source>
<year>2007</year>
<volume>46</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>922-38</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lemoine]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Katsahian]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ziol]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nahon]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ganne-Carrie]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Kazemi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis]]></article-title>
<source><![CDATA[Aliment Pharmacol Ther]]></source>
<year>2008</year>
<volume>28</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1102-10</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Robic]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Procopet]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Métivier]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Péron]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Selves]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Vinel]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease a prospective study]]></article-title>
<source><![CDATA[J Hepatol]]></source>
<year>2011</year>
<volume>55</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1017-24</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shi]]></surname>
<given-names><![CDATA[KQ]]></given-names>
</name>
<name>
<surname><![CDATA[Fan]]></surname>
<given-names><![CDATA[YC]]></given-names>
</name>
<name>
<surname><![CDATA[Pan]]></surname>
<given-names><![CDATA[ZZ]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[XF]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[WY]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[YP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transient elastography a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease]]></article-title>
<source><![CDATA[Liver Int]]></source>
<year>2013</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>62-71</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roccarina]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Rosselli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Genesca]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tsochatzis]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Elastography methods for the non-invasive assessment of portal hypertension]]></article-title>
<source><![CDATA[Expert Rev Gastroenterol Hepatol]]></source>
<year>2018</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>155-64</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reiberger]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Ferlitsch]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Payer]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Pinter]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Homoncik]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Peck-Radosavljevic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Non-selective ß-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis]]></article-title>
<source><![CDATA[J Gastroenterol]]></source>
<year>2012</year>
<volume>47</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>561-8</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Franchis]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Abraldes]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Bajaj]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Berzigotti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bosch]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Burroughs]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension]]></article-title>
<source><![CDATA[J Hepatol]]></source>
<year>2015</year>
<page-range>743-52</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Augustin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pons]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Maurice]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Bureau]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Stefanescu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ney]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease]]></article-title>
<source><![CDATA[Hepatology]]></source>
<year>2017</year>
<volume>66</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1980-8</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dean]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Sullivan]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Soe]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<source><![CDATA[OpenEpi: Open Source Epidemiologic Statistics for Public Health (base de datos en Internet),]]></source>
<year>2007</year>
<publisher-loc><![CDATA[Atlanta ]]></publisher-loc>
<publisher-name><![CDATA[Open Epi]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Colombato]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bandi]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Mendizabal]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Paz]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Súarez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Villaverde]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guías de manejo de las varices esófago-gástricas]]></article-title>
<source><![CDATA[AAEEH]]></source>
<year>2015</year>
<numero>1004</numero>
<issue>1004</issue>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guillén Isern]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Subirat Esquivel]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consideraciones actuales de la gastropatía hipertensiva portal]]></article-title>
<source><![CDATA[Rev Arch Médico Camagüey]]></source>
<year>2011</year>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>626-37</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<collab>Junta Nacional de Drogas</collab>
<source><![CDATA[Drogas: más información, menos riesgos. 6° ed]]></source>
<year>2007</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[IMPO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Objetivos Sanitarios Nacionales 2020 (Internet)]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[MSP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández]]></surname>
</name>
</person-group>
<collab>N</collab>
<source><![CDATA[Situación del VHC en Uruguay (Internet)]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Clínica de Gastroenterología]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Qamar]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Grace]]></surname>
<given-names><![CDATA[ND]]></given-names>
</name>
<name>
<surname><![CDATA[Groszmann]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia-tsao]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bosch]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Burroughs]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
</person-group>
<source><![CDATA[Platelet Count Is Not a Predictor of the Presence or Development of Gastro esophageal Varices in Cirrhosis]]></source>
<year>2008</year>
<publisher-name><![CDATA[AASLD]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
